Lijnen Paul J, Petrov Victor V, Fagard Robert H
Hypertension and Cardiovascular Rehabilitation Unit, Department of Molecular and Cardiovascular Research, Catholic University of Leuven (K.U. Leuven), Belgium.
J Hypertens. 2004 Jan;22(1):209-16. doi: 10.1097/00004872-200401000-00031.
To determine whether lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, and bestatin, an aminopeptidase inhibitor with broad specificity, could affect collagen production in control and transforming growth factor (TGF)-beta1-treated cardiac fibroblasts.
Cardiac fibroblasts from passage 2 from normal male adult rats were cultured to confluency, incubated with or without 600 pmol/l TGF-beta1 for 2 days in serum-free Dulbecco's modified Eagle's medium and then incubated with the test products (lisinopril or bestatin) for 1 day in this medium with added ascorbic acid, beta-aminoproprionitrile and tritiated proline. Soluble collagen was measured in the conditioned medium and non-soluble collagen in the cell layer. ACE activity was measured fluorimetrically with hippuryl-histidyl-leucine as substrate, and DNA with the bisbenzimide dye, Hoechst 33,258. Aminopeptidase activity was estimated by spectrophotometric determination of the liberation of p-nitroaniline from alanine-p-nitroanilide.
Lisinopril dose-dependently reduced ACE activity in control and TGF-beta1-treated cardiac fibroblasts. Bestatin inhibited the basal and TGF-beta1-stimulated aminopeptidase activity in a concentration-dependent manner. Lisinopril (10 micromol/l) decreased (P < 0.05) the production of soluble and non-soluble collagen in control cardiac fibroblasts. TGF-beta1 (600 pmol/l) increased (P < 0.05) the production of soluble and non-soluble collagen, and this effect was decreased (P < 0.05) by lisinopril. Bestatin (100 micromol/l) reduced (P < 0.01) the production of soluble collagen in control and TGF-beta1-treated cardiac fibroblasts, but did not affect the production of non-soluble collagen in these cells.
Our data suggest that ACE and aminopeptidases are involved in the basal and TGF-beta1-stimulated production of collagen in adult rat cardiac fibroblasts in culture.
确定血管紧张素转换酶(ACE)抑制剂赖诺普利和具有广泛特异性的氨肽酶抑制剂贝司他汀是否会影响对照及经转化生长因子(TGF)-β1处理的心脏成纤维细胞中的胶原蛋白生成。
将来自正常成年雄性大鼠的第2代心脏成纤维细胞培养至汇合状态,在无血清的杜尔贝科改良伊格尔培养基中,分别在有或无600 pmol/l TGF-β1的条件下孵育2天,然后在此添加了抗坏血酸、β-氨基丙腈和氚标记脯氨酸的培养基中,与测试产品(赖诺普利或贝司他汀)一起孵育1天。测定条件培养基中的可溶性胶原蛋白以及细胞层中的不可溶性胶原蛋白。以马尿酰-组氨酰-亮氨酸为底物,通过荧光法测定ACE活性,用双苯甲酰亚胺染料Hoechst 33258测定DNA。通过分光光度法测定从丙氨酸-对硝基苯胺释放对硝基苯胺来估算氨肽酶活性。
赖诺普利以剂量依赖的方式降低对照及经TGF-β1处理的心脏成纤维细胞中的ACE活性。贝司他汀以浓度依赖的方式抑制基础及TGF-β1刺激的氨肽酶活性。赖诺普利(10 μmol/l)降低(P < 0.05)对照心脏成纤维细胞中可溶性和不可溶性胶原蛋白的生成。TGF-β1(600 pmol/l)增加(P < 0.05)可溶性和不可溶性胶原蛋白的生成,而赖诺普利可降低(P < 0.05)这种作用。贝司他汀(100 μmol/l)降低(P < 0.01)对照及经TGF-β1处理的心脏成纤维细胞中可溶性胶原蛋白的生成,但不影响这些细胞中不可溶性胶原蛋白的生成。
我们的数据表明,ACE和氨肽酶参与培养的成年大鼠心脏成纤维细胞中基础及TGF-β1刺激的胶原蛋白生成。